| Literature DB >> 35629315 |
Ramesh Chandra Poonia1, Abdul Khader Jilani Saudagar2, Abdullah Altameem2, Mohammed Alkhathami2, Muhammad Badruddin Khan2, Mozaherul Hoque Abul Hasanat2.
Abstract
Currently, the spread of COVID-19 is running at a constant pace. The current situation is not so alarming, but every pandemic has a history of three waves. Two waves have been seen, and now expecting the third wave. Compartmental models are one of the methods that predict the severity of a pandemic. An enhanced SEIR model is expected to predict the new cases of COVID-19. The proposed model has an additional compartment of vaccination. This proposed model is the SEIRV model that predicts the severity of COVID-19 when the population is vaccinated. The proposed model is simulated with three conditions. The first condition is when social distancing is not incorporated, while the second condition is when social distancing is included. The third one condition is when social distancing is combined when the population is vaccinated. The result shows an epidemic growth rate of about 0.06 per day, and the number of infected people doubles every 10.7 days. Still, with imparting social distancing, the proposed model obtained the value of R0 is 1.3. Vaccination of infants and kids will be considered as future work.Entities:
Keywords: COVID-19; SEIR model; SEIRV; social distancing; vaccination
Year: 2022 PMID: 35629315 PMCID: PMC9145292 DOI: 10.3390/life12050647
Source DB: PubMed Journal: Life (Basel) ISSN: 2075-1729
Vaccines Approved by WHO.
| S. N. | Name of Company | Name of Vaccine |
|---|---|---|
| 1 | Moderna | mRNA-1273 |
| 2 | Pfizer/BioNTech | BNT162b2 |
| 3 | Janssen (Johnson & Johnson) | Ad26.COV2.S |
| 4 | Oxford/AstraZeneca | AZD1222 |
| 5 | Serum Institute of India | Covishield |
| 6 | Bharat Biotech | Covaxin |
| 7 | Sinopharm (Beijing) | BBIBP-CorV (Vero Cells) |
| 8 | Sinovac | CoronaVac |
Country-wise vaccination rates.
| S. N. | Name of Country | % of Population Fully Vaccination |
|---|---|---|
| 1 | India | 37.3% |
| 2 | United States | 60.8% |
| 3 | Brazil | 65.6% |
| 4 | Indonesia | 37.7% |
| 5 | Japan | 77.9% |
| 6 | Russia | 42.6% |
| 7 | Germany | 69.5% |
| 8 | United Kingdom | 69.5% |
| 9 | France | 71.0% |
| 10 | Iran | 57.3% |
| 11 | Saudi Arabia | 65.5% |
| 12 | Egypt | 16.4% |
| 13 | South Africa | 25.8% |
| 14 | United Arab Emirates | 91.1% |
| 15 | Nigeria | 1.9% |
Different compartment models.
| S. N. | Acronym | Name of Model | Parameter Added | Definition |
|---|---|---|---|---|
| 1 | SIS [ | Susceptible-Infectious-Susceptible | Simplest form | Immunity does not build |
| 2 | SIRD [ | Susceptible-Infectious-Recovered-Deceased | Deceased | D is the mortality rate |
| 3 | MSIR [ | Maternal-Susceptible-Infectious-Recovered | Maternally Derived Immune | Newborn babies which are immune to a specific disease, such as measles |
| 4 | SICR [ | Susceptible-Infectious-Carrier-Recovered | Carrier | It is applicable on those where infection resides in the body forever, such as TB |
| 5 | SUQC [ | Susceptible-Unquarantined, Quarantine-Confirmed | Unquarantined, Quarantine | Number of people who are quarantined and unquarantined. |
| 6 | GSIR [ | Generalized-Susceptible-Infectious-Recovered | Generalized | Assumed that throughout time, many waves of varied peak amplitude and form arise and fade away |
| 7 | SEIHR [ | Generalized-Susceptible-Infectious-Hospitalized-Recovered | Hospitalized | Number of persons hospitalized |
| 8 | SCEIR [ | Susceptible-Exposed-Infectious-Recovered-Removed | Confined | When an individual is experiencing lockdown |
| 9 | ISSEIR [ | Interacting Subpopulation- Susceptible-Exposed-Infectious-Recovered | Interacting Subpopulation | Separate SEIR model between each subgroup of the population |
| 10 | SEIRV [ | Susceptible-Infectious-Recovered-Vaccination | Vaccination | When the population is vaccinated |
Figure 1Proposed Model. Ψ—The rate at which individuals are vaccinated, γ—Rate at which infected individuals in class I1, I2 and I3 recovered from the disease and immunity is developed, β—Rate at which one infected in class I1, I2 and I3 contact susceptible and infect all of them. Thus, the susceptible individuals changed to exposed individuals, I1—Rate of mild infection and hospitalization.
Figure 2Trends of number of people in different categories over a period of 365 days without social distancing and vaccination. Susceptible individuals (S), Exposed individuals (E), Individuals who have recovered from the disease and have become immune (R), Dead individuals (D), and Vaccinated individuals (V), Individuals suffer with mild infection who do not require hospitalization (I1), Individuals with severe infection who require hospitalization (I2), Individuals with critical infection who require admittance to ICU (I3).
Figure 3Impact of Social Distancing on number of cases in various categories. Susceptible individuals (S), Exposed individuals (E), Individuals who have recovered from the disease and have become immune (R), Dead individuals (D), and Vaccinated individuals (V), Individuals suffer with mild infection who do not require hospitalization (I1), Individuals with severe infection who require hospi-talization (I2), Individuals with critical infection who require admittance to ICU (I3).
Figure 4Impact of social distancing and vaccination.
Coefficient of the proposed methods.
| Name of Coefficient | Definition |
|---|---|
|
| Total population (comprising 1000 individuals in this research) |
|
| Susceptible individuals |
|
| Rate at which one infected in class |
|
| Rate at which one infected in class |
|
| Rate at which one infected in class |
|
| Rate of mild infection and hospitalization not required. |
|
| Rate of severe infection and hospitalization is required. |
|
| Rate of critical infection and I.C.U. is required. |
|
| Set of exposed individuals; they are infected but not asymptotic and infectious. |
|
| Set of vaccinated persons. |
|
| Rate at which infected individuals in class |
|
| Rate at which infected individuals in class |
|
| Rate at which infected individuals in class |
|
| Rate at which one infected in class |
|
| Rate at which one infected in class |
|
| Set of individuals who have recovered from the disease and are now immune. |
| λ | Rate of natural (those who are not deceased from the COVID-19). |
|
| The death rate of individuals in the most severe stage of disease. |
| Ψ | The rate at which individuals are vaccinated |
| η | Vaccine inefficacy |
|
| Set of removed populations |
Obtained values of coefficients.
| Coefficient | Crude Birth Rate (σ) | λ | η | ψ |
|---|---|---|---|---|
|
| 0.0 | 0.00025 | 0.0 | 0.0 |
| α | 0.2 | - | - | - |
|
| 0.0 | 0.08 | 0.06818182 | 0.08571429 |
|
| 0.0 | 0.02 | 0.02272727 | - |
|
| 0.057142857 | - | - | - |
Figure 5Compare to the cases with intervention.
Figure 6Trends of ventilation support.